Corona’s parent is looking for more beer drinkers. Why Budweiser could be the buzzkill.
ICE raids have hurt beer demand for Corona’s parent company. Its search for sales elsewhere could hit these obstacles. View Source Bill Peters MarketWatch.com –…
Category: MarketWatch
Caterpillar expects up to $1.5 billion in tariff costs this year, and the stock is rising
Caterpillar shares are rising in morning trades, after the maker of construction and mining equipment missed second-quarter profit expectations but beat on sales and raised…
Why your credit-card company might jack up your card’s APR even when the Fed holds rates steady
The average annual percentage rate on new credit-card offers has increased for four consecutive months, one expert noted. View Source Andrew Keshner MarketWatch.com – Top…
NASA reportedly wants to put a nuclear reactor on the moon. This company’s stock is soaring.
Shares of BWX Technologies hit a record high, as investors believe the nuclear-power company could be involved in NASA’s lunar plans. View Source James Rogers…
This ‘genius’ hack has cleared my email inbox completely
How I found inner peace by hitting “delete.” View Source Brett Arends MarketWatch.com – Top Stories August 5, 2025 9:43 am
Trump threatens drugmakers with 250% tariffs. Here’s when higher levies could come.
The latest level of tariffs on the pharmaceutical industry is the highest yet from the president. View Source Robert Schroeder MarketWatch.com – Top Stories August…
JPMorgan and Bank of America stocks drop as Trump warns of payback for ‘bad’ treatment
Big banks said they agree with President Donald Trump that financial regulations need an overhaul, even as their stock prices dropped Tuesday after the president…
Biggest part of the U.S. economy barely grows in July, ISM finds, due to tariff knock-on effects
ISM services index shows higher inflation and less employment View Source Jeffry Bartash MarketWatch.com – Top Stories August 5, 2025 7:25 am
Pfizer boosts profit estimate, even as the drug giant absorbs tariffs
Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter…
Palantir skeptics double down on a concern that investors have been better off ignoring
Many analysts note that Palantir’s stock is expensive, but that hasn’t stopped the S&P 500’s top performer from adding to its huge gains. View Source…